Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Johnson and Johnson (France)

Below is an extended Johnson and Johnson (France) news listing. Click here to return to the Johnson and Johnson (France) main Biocorporate entry.

BioNews Results for Johnson and Johnson (France):
Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential - new report PR inside: Nov 3 2009 7:37PM Matching: johnson france
Sunday start for Amgen Tour considered a boon for tourism San Francisco Business Times: Oct 30 2009 9:20PM Matching: johnson france
Analysis of the current and future anticonvulsant drug class market News-Medical.Net: Oct 29 2009 9:33AM Matching: johnson france
Winning placement on Managed Care formularies, the first step for product's increased market share News-Medical.Net: Oct 29 2009 10:20AM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Forbes.com: Oct 28 2009 4:29PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster Business Wire: Oct 28 2009 4:10PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster Potential Analyse Forecasts Up To 2018 Earthtimes.org: Oct 28 2009 4:08PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster RBC Dain Rauscher: Oct 28 2009 4:08PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster Yahoo! Canada: Oct 28 2009 4:07PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster Business Wire via Yahoo!: Oct 28 2009 4:04PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster Business Wire UK: Oct 28 2009 4:04PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster Business Wire: Oct 28 2009 4:02PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster PR inside: Oct 28 2009 4:20PM Matching: johnson france
Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential By Bharatboo PRMinds: Oct 28 2009 4:03PM Matching: johnson france
Amgen 2010 Tour's first leg: Nevada City to Sacramento Sacramento Business Journal: Oct 24 2009 3:30AM Matching: johnson france

«Johnson and Johnson (France)

This page contained an extended Johnson and Johnson (France) news listing. Click here to return to the Johnson and Johnson (France) main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.